AVANT IMMUNOTHERAPEUTICS INC
BalancedAVAN·US·🇺🇸 US
52%buys·48%sells
577 transactions$11.2MTotal buys·58 buys
$49.4MTotal sells·53 sells
4444 insiders
Last: Dec 15, 2025
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Dec 15, 25 | PEPIN RONALD | Exercise | - | |
| Dec 15, 25 | PEPIN RONALD | Exercise | - | |
| Dec 15, 25 | PEPIN RONALD | Exercise | $31K | |
| Dec 15, 25 | PEPIN RONALD | Exercise | $75K | |
| Dec 4, 25 | Jimenez Freddy A. | Sell | $121K | |
| Nov 13, 25 | Wright Richard M. | Exercise | - | |
| Nov 13, 25 | Wright Richard M. | Exercise | - | |
| Nov 13, 25 | Wright Richard M. | Exercise | - | |
| Nov 13, 25 | Wright Richard M. | Exercise | $354K | |
| Nov 13, 25 | Wright Richard M. | Exercise | $277K |
AVANT IMMUNOTHERAPEUTICS INC (AVAN) has recorded 577 insider transactions from 44 insiders. Total insider buying volume stands at $11.2M, while total selling volume is $49.4M. Insider activity shows a balanced mix of buying and selling.
AVANT IMMUNOTHERAPEUTICS INC (AVAN) has recorded 577 insider operations, including 58 open-market purchases ($11.2M), 53 sales ($49.4M) and 466 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is balanced.
AVANT IMMUNOTHERAPEUTICS INC shows moderate insider activity with 4 active months out of the last 12, typical of a company whose trading windows are concentrated around financial disclosures.
Among the most active insiders are RYAN UNA S (CEO), Marucci Anthony S (CEO) & CATLIN AVERY W (CFO), with respectively 54, 44, 69 transactions.
Across all 577 recorded transactions, the breakdown by type is: grant (298, 52%), exercise (144, 25%), buys (58, 10%), sells (53, 9%), tax (22, 4%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
AVANT IMMUNOTHERAPEUTICS INC has recorded 577 insider operations in total, including 58 open-market purchases ($11.2M), 53 sales ($49.4M) and 466 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on December 15, 2025.
Insiders at AVANT IMMUNOTHERAPEUTICS INC show balanced activity with 52% purchases and 48% sales. Total buy volume is $11.2M versus $49.4M in sales.
InsiderLens tracks 44 insiders at AVANT IMMUNOTHERAPEUTICS INC (AVAN). RYAN UNA S (CEO, 54 tx), Marucci Anthony S (CEO, 44 tx), CATLIN AVERY W (CFO, 69 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for AVAN is neutral, based on a 52% buy ratio across 111 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for AVANT IMMUNOTHERAPEUTICS INC comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.